Subsidiaries
Acceleron Pharma | Cubist Pharmaceuticals | H. K. Mulford Company | Schering-Plough | Viralytics | Merck Sharp & Dohme
Current pharmaceutical products
Antivenin | Arcoxia | Belsomra | Bridion | Cancidas | Cubicin | Delstrigo | Dificid | Emend | Entereg | Ervebo | Follistim | Gardasil | Intron | Invanz | Isentress | Janumet | Januvia | Keytruda | M-M-R | Noxafil | Liquid Pedvax HIB | Pifeltro | Pneumovax | Pregnyl | Prevymis | Primaxin | ProQuad | Proventil | Recarbrio | Recombivax HB | RotaTeq | Segluromet | Sivextro | Steglatro | Steglujan | Stromectol | Temodar | Tice | Trusopt | Vaqta | Varivax | Vaxelis | Vaxneuvance | Verquvo | Welireg | Zepatier | Zerbaxa | Zinplava | Zolina
Former/defunct assets
Brands: Claritin | Coppertone | Crixivan | Eukodal | Foradil Aerolizer | Liptruzet | Victrelis | Vioxx
Subsidiaries: Organon
| 
